{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:53:13Z","timestamp":1781088793605,"version":"3.54.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":1013,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1002\/rth2.12318","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T05:31:16Z","timestamp":1583127076000},"page":"429-432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Thrombin generation in a woman with heterozygous factor V Leiden and combined oral contraceptives: A case report"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9298-8268","authenticated-orcid":false,"given":"Maxime G.","family":"Zermatten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9756-4974","authenticated-orcid":false,"given":"Debora","family":"Bertaggia Calderara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9382-138X","authenticated-orcid":false,"given":"Alessandro","family":"Aliotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9686-9920","authenticated-orcid":false,"given":"Lorenzo","family":"Alberio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/rth2.12318_bb0010","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/AOG.0b013e3182994c43","article-title":"Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta\u2010analysis","volume":"122","author":"Peragallo Urrutia","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1002\/rth2.12318_bb0015","doi-asserted-by":"crossref","first-page":"B2921","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the mega case\u2010control study","volume":"339","author":"Van Hylckama","year":"2009","journal-title":"BMJ"},{"key":"10.1002\/rth2.12318_bb0020","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1542\/peds.2010-2221","article-title":"Hormonal contraception and thrombotic risk: a multidisciplinary approach","volume":"127","author":"Trenor","year":"2011","journal-title":"Pediatrics"},{"key":"10.1002\/rth2.12318_bb0025","doi-asserted-by":"crossref","first-page":"232840","DOI":"10.1155\/2011\/232840","article-title":"Acquired activated protein c resistance, thrombophilia and adverse pregnancy outcomes: a study performed in an Irish cohort of pregnant women","volume":"2011","author":"Sedano\u2010Balbas","year":"2011","journal-title":"J Pregnancy"},{"key":"10.1002\/rth2.12318_bb0030","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/MBC.0b013e3282f09835","article-title":"Haemostatic changes and acquired activated protein C resistance in normal pregnancy","volume":"18","author":"Mahieu","year":"2007","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1002\/rth2.12318_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/GIM.0b013e3181faa0f2","article-title":"Leiden thrombophilia","volume":"13","author":"Kujovich","year":"2011","journal-title":"Genet Med"},{"key":"10.1002\/rth2.12318_bb0040","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(94)90286-0","article-title":"Increased risk of venous thrombosis in oral\u2010contraceptive users who are carriers of factor V Leiden mutation","volume":"344","author":"Vandenbroucke","year":"1994","journal-title":"Lancet"},{"key":"10.1002\/rth2.12318_bb0045","doi-asserted-by":"crossref","first-page":"H2135","DOI":"10.1136\/bmj.h2135","article-title":"Use of combined oral contraceptives and risk of venous thromboembolism: nested case\u2010control studies using the Qresearch and CPRD databases","volume":"350","author":"Vinogradova","year":"2015","journal-title":"BMJ"},{"key":"10.1002\/rth2.12318_bb0050","doi-asserted-by":"crossref","first-page":"B2890","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow\u2010up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"BMJ"},{"key":"10.1002\/rth2.12318_bb0055","first-page":"547","article-title":"Thrombin generation assessed as endogenous thrombin potential in patients with hyper\u2010 or hypo\u2010coagulability","volume":"88","author":"Chantarangkul","year":"2003","journal-title":"Haematologica"},{"key":"10.1002\/rth2.12318_bb0060","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1055\/s-0038-1649707","article-title":"The influence of oral contraceptives on the time\u2010integral of thrombin generation (thrombin potential)","volume":"70","author":"Rotteveel","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1002\/rth2.12318_bb0065","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.thromres.2014.09.008","article-title":"Changes in haemostatic parameters during the menstrual cycle and subsequent use of drospirenone\u2010containing oral contraceptives","volume":"134","author":"Tchaikovski","year":"2014","journal-title":"Thromb Res"},{"key":"10.1002\/rth2.12318_bb0070","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0140-6736(99)06092-4","article-title":"Low\u2010dose oral contraceptives and acquired resistance to activated protein C: a randomised cross\u2010over study","volume":"354","author":"Rosing","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/rth2.12318_bb0075","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12185-015-1898-6","article-title":"Thrombin generation and other coagulation parameters in a patient with homozygous congenital protein S deficiency on treatment with rivaroxaban","volume":"103","author":"Tripodi","year":"2016","journal-title":"Int J Hematol"},{"key":"10.1002\/rth2.12318_bb0080","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1111\/ijlh.12767","article-title":"Effect of rivaroxaban on thrombin generation in vivo. A study in obese patients","volume":"40","author":"Bertaggia\u2010Calderara","year":"2018","journal-title":"Int J Lab Hematol"},{"key":"10.1002\/rth2.12318_bb0085","doi-asserted-by":"crossref","first-page":"E426","DOI":"10.1016\/S2352-3026(16)30079-5","article-title":"Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open\u2010label, phase 2\/3, non\u2010inferiority trial","volume":"3","author":"Cohen","year":"2016","journal-title":"Lancet Haematol"},{"key":"10.1002\/rth2.12318_bb0090","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/rth2.12044","article-title":"Assessment of the effect of direct oral anticoagulants dabigatran, rivaroxaban, and apixaban in healthy male volunteers using a thrombin generation assay","volume":"1","author":"Artang","year":"2017","journal-title":"Res Pract Thromb Haemost"},{"issue":"8","key":"10.1002\/rth2.12318_bb0095","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood-2011-03-345678","article-title":"Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception","volume":"118","author":"Van Vlijmen","year":"2011","journal-title":"Blood"},{"key":"10.1002\/rth2.12318_bb0100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.thromres.2019.04.033","article-title":"A review of global coagulation assays \u2010 is there a role in thrombosis risk prediction?","volume":"179","author":"Lim","year":"2019","journal-title":"Thromb Res"},{"key":"10.1002\/rth2.12318_bb0105","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.blre.2018.08.001","article-title":"Everything the clinician needs to know about evidence\u2010based anticoagulation in pregnancy","volume":"33","author":"Scheres","year":"2019","journal-title":"Blood Rev"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Frth2.12318","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12318","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/rth2.12318","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922019914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922019914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12318","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:18:59Z","timestamp":1762863539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037922019914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S2475037922019914"],"URL":"https:\/\/doi.org\/10.1002\/rth2.12318","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombin generation in a woman with heterozygous factor V Leiden and combined oral contraceptives: A case report","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1002\/rth2.12318","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 The Authors. Research and Practice in Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis","name":"copyright","label":"Copyright"}]}}